Thus, in this study, we aimed to determine whether GRK5 inhibition via GRK5-IN-2 in vivo could promote adipose tissue remodeling and improve metabolic health in diet-induced obesity. This evidence concerns the gene GRK5 and obesity due to melanocortin 4 receptor deficiency.